Dose–time fractionation schedules of preoperative radiotherapy and timing to surgery for rectal cancer

Bibliographic Details
Title: Dose–time fractionation schedules of preoperative radiotherapy and timing to surgery for rectal cancer
Authors: Fu Jin, Huanli Luo, Juan Zhou, Yongzhong Wu, Hao Sun, Hongliang Liu, Xiaodong Zheng, Ying Wang
Source: Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Publisher Information: SAGE Publishing, 2020.
Publication Year: 2020
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Chemoradiotherapy (CRT) is extensively used prior to surgery for rectal cancer to provide significantly better local control, but the radiotherapy (RT), as the other component of CRT, has been subject to less interest than the drug component in recent years. With considerable developments in RT, the use of advanced techniques, such as intensity-modulated radiotherapy (IMRT) in rectal cancer, is garnering more attention nowadays. The radiation dose can be better conformed to the target volumes with possibilities for synchronous integrated boost without increased complications in normal tissue. Hopefully, both local recurrence and toxicities can be further reduced. Although those seem to be of interest, many issues remain unresolved. There is no international consensus regarding the radiation schedule for preoperative RT for rectal cancer. Moreover, an enormous disparity exists regarding the RT delivery. With the advent of IMRT, variations will likely increase. Moreover, time to surgery is also quite variable, as it depends upon the indication for RT/CRT in the clinical practices. In this review, we discuss the options and problems related to both the dose–time fractionation schedule and time to surgery; furthermore, it addresses the research questions that need answering in the future.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1758-8359
17588359
Relation: https://doaj.org/toc/1758-8359
DOI: 10.1177/1758835920907537
Access URL: https://doaj.org/article/14e944696c1449868fa61ffc1678afa0
Accession Number: edsdoj.14e944696c1449868fa61ffc1678afa0
Database: Directory of Open Access Journals
More Details
ISSN:17588359
DOI:10.1177/1758835920907537
Published in:Therapeutic Advances in Medical Oncology
Language:English